NEW USE OF A674563 IN ACUTE LEUKEMIA CARRYING FLT3 MUTANT GENE

摘要

Disclosed is the use of A674563 in the preparation of a medicine for treating acute myeloid leukaemia patients carrying the FLT3 mutant gene, wherein a patient with leukemia may or may not have a tolerance associated with the high expression of the FL ligand. Also disclosed is method for inhibiting acute myeloid leukemia cells carrying the FLT3 mutant gene with non-therapeutic purposes, comprising the cells being in contact with A674563.